Skip to main content

Animations

MJFF Publications

2631 - 2640 of 8654 Results
Title
Year
  • Year
  • 2024
  • 2021
  • 2012
  • 2017
  • 2022
  • 2019
  • 2020
  • 2018
  • 2021
  • 2018
  • Summary Details
    OPEN
    Title: LRRK2 kinase inhibition reverses G2019S mutation-dependent effects on tau pathology progression
    Journal Name: Translational Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s40035-024-00403-2
    Citation Count: 10
  • Summary Details
    RESTRICTED
    Title: Leucine rich repeat kinase 2 (LRRK2) peptide modulators: Recent advances and future directions
    Journal Name: Peptide Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/pep2.24251
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Is Freezing of Gait in Parkinson's Disease a Result of Multiple Gait Impairments? Implications for Treatment
    Journal Name: Parkinson's Disease
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2012/459321
    Citation Count: 110
  • Summary Details
    RESTRICTED
    Title: Square biphasic pulse deep brain stimulation for essential tremor: The BiP tremor study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.10.015
    Best OA location URL:
    Citation Count: 28
  • Summary Details
    RESTRICTED
    Title: A late-onset neurological disorder: is progression inevitable?
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.014
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competition
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2019.104577
    Citation Count: 41
  • Summary Details
    OPEN
    Title: Longitudinal Measurements of Glucocerebrosidase activity in Parkinson’s patients
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.51164
    Citation Count: 38
  • Summary Details
    OPEN
    Title: Cortical atrophy patterns in early Parkinson's disease patients using hierarchical cluster analysis
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.02.006
    Citation Count: 71
  • Summary Details
    OPEN
    Title: Small Molecule Improvement of Trafficking Defects in Models of Neurodegeneration
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acschemneuro.1c00524
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.02.007
    Citation Count: 126
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.